O2h Ventures Overview
o2h Ventures focuses on seeding early-stage biotech therapeutics and related AI opportunities, investing in companies qualifying under the UK's Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS).
Is O2h Ventures the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with O2h Ventures, along with a list of other relevant VCs, is available on Hopohopo.io.
O2h Ventures
Investment focus
Invest in
- Western Europe 1 / 14
Customer types
- B2B
Product type
- Drugs / Pharma
Industries / verticals
- AI Infrastructure & AI Model Development
- BioTech & Life Sciences
- PharmaTech
Investment role
Lead and follow
Stages
Pre-seed, Seed, Series A
First ticket size
£100,000 - £1,500,000
How to approach funds like O2h Ventures
When reaching out to o2h Ventures, founders should highlight the scientific rigor and translational potential of their biotech or AI-driven therapeutic innovation, especially if it leverages UK-based research or talent. Demonstrating a clear path to early proof-of-concept and a strong, multidisciplinary founding team will resonate, as will a well-articulated plan for leveraging EIS/SEIS advantages. o2h values founders who can articulate both the commercial and clinical impact of their solution within the UK ecosystem.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
